Clinical trial
A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects…
NCT00351325 · Bristol-Myers Squibb, Industry · Terminated
Key facts
| NCT number | NCT00351325 |
|---|---|
| Title | A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies |
| Official title | A Phase I, Multiple Ascending Dose Study of BMS-663513, an Agonistic Anti-CD137 Monoclonal Antibody, Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Solid Malignancies |
| Intervention type | Drug |
| Interventions | BMS-663513 |
| Enrollment | 45 |
| Start date | Sep 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jul 12, 2006 |
| Last update posted | Sep 4, 2009 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: